Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis

Area of Science:

• Biochemistry
• Developmental Biology
• Pharmacology

Background:

• Cytochrome P450 (CYP) enzymes are crucial for drug metabolism and detoxification.
• Understanding CYP expression in embryonic development is vital for assessing fetal drug exposure risks.

Purpose of the Study:

• To investigate the expression and function of cytochrome P450 (CYP) isoforms in human embryonic tissues during organogenesis (days 50-60 of gestation).
• To identify specific CYP3A subfamily members expressed in early human embryonic liver and their metabolic capabilities.

Main Methods:

• Utilized substrate and inhibitor probes, immunoprobes, and reverse transcription-polymerase chain reaction (RT-PCR) for CYP isoform analysis.
• Cloned and sequenced CYP3A complementary DNA (cDNA) from embryonic hepatic tissues.
• Analyzed (R)-warfarin hydroxylation and O-debenzylation of benzyloxyresorufin using embryonic hepatic microsomal fractions.

Main Results:

• High levels of functional CYP3A isoforms were detected in embryonic livers, evidenced by (R)-warfarin hydroxylation and triacetyloleandomycin-inhibited O-debenzylation.
• Immunoblots showed strong CYP3A signals in embryonic hepatic tissues, but negligible levels in lung, kidney, heart, adrenal, and brain.
• Sequencing of amplified CYP3A cDNA revealed predominant expression of CYP3A7 (58/59 clones) and minimal CYP3A5 (1/59 clones), with no evidence for CYP3A3 or CYP3A4.

Conclusions:

• Human embryonic hepatic tissues primarily express CYP3A7 during organogenesis (days 50-60).
• The embryonic liver is capable of significant CYP3A7-catalyzed xenobiotic monooxygenation at this early gestational stage.
• This early expression suggests potential fetal susceptibility to xenobiotics and highlights the importance of CYP3A7 in embryonic development.